Printer Friendly

COLUMBIA LABORATORIES REPORTS WARNER-LAMBERT TO MARKET REPLENS IN CANADA

COLUMBIA LABORATORIES REPORTS WARNER-LAMBERT TO MARKET REPLENS IN CANADA
 HOLLYWOOD, Fla., Aug. 17 /PRNewswire/ -- Columbia Laboratories, Inc. (AMEX: COB) reported that Warner-Lambert Company has notified Columbia of its intention to exercise its option, under a previous agreement, to market Replens in Canada.
 Warner-Lambert is currently marketing Replens, a vaginal moisturizer utilizing Columbia's patented bioadhesive technology, in the United States. "We are pleased that Warner-Lambert has decided to expand its marketing activities for Replens throughout North America," said Norman M. Meier, Columbia's president and chief executive officer.
 Columbia Laboratories, Inc. is a U.S.-based international pharmaceutical company, established in 1987, whose objective is to develop and market on a worldwide basis, either directly or through corporate partners, a portfolio of prescription and over-the-counter drugs and cosmetics, which utilize the company's patented substance delivery technology.
 -0- 8/17/92
 /CONTACT: Margaret J. Roell, chief financial officer of Columbia Laboratories, Inc., 305-985-6545/
 (COB) CO: Columbia Laboratories, Inc.; Warner-Lambert Company ST: Florida IN: HEA MTC SU:


AW-JJ -- FL011 -- 0488 08/17/92 11:58 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 17, 1992
Words:172
Previous Article:MORTON INTERNATIONAL DECLARES QUARTERLY DIVIDEND
Next Article:OPTROTECH AGREES TO MERGE WITH ORBOT
Topics:


Related Articles
COLUMBIA LABORATORIES SIGNS LETTER OF INTENT TO LICENSE AND SUPPLY REPLENS AND OTHER WOMEN'S OTC HEALTH CARE PRODUCTS
COLUMBIA LABORATORIES REPORTS NINE MONTHS AND THIRD QUARTER 1991 RESULTS
WARNER-LAMBERT COMPANY TO MARKET COLUMBIA LABORATORIES' REPLENS: AGREEMENT SIGNED FOR LICENSE AND SUPPLY ARRANGEMENT
COLUMBIA LABORATORIES REPORTS FISCAL 1991 RESULTS; OPERATING AND NET LOSSES DECREASE
COLUMBIA LABORATORIES REPORTS FIRST QUARTER 1992 RESULTS; NET LOSS DROPS 58 PERCENT, MULTINATIONAL PARTNERS MARKET REPLENS
COLUMBIA LABORATORIES EXPANDS WORLDWIDE MARKETING OF REPLENS(R) LOGOS AGREEMENT
TEVA PHARMACEUTICALS TO MARKET COLUMBIA LABORATORIES' WOMEN'S HEALTH CARE PRODUCTS IN ISRAEL
COLUMBIA LABORATORIES REPORTS 1992 FINANCIAL RESULTS; NET LOSS SIGNIFICANTLY DECREASED
ROBERTS PHARMACEUTICAL OBTAINS EXCLUSIVE CANADIAN RIGHTS TO REPLENS FROM COLUMBIA LABORATORIES
ROBERTS PHARMACEUTICAL CORPORATION PREPARES CANADIAN LAUNCH OF ADVANTAGE 24;

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters